Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.
Zepbound is a medication containing tirzepatide, which the preliminary study showed to be more effective for weight loss than Wegovy, which contains semaglutide. This preliminary study ...
Treatment with Zepbound, whose generic name is tirzepatide, led to improvements ... That equates to 45 to 50 pounds of weight loss, on average, over a year, Lilly said. Patients on the drug ...